Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VVOS |
---|---|---|
09:32 ET | 209 | 2.71 |
09:39 ET | 1000 | 2.6601 |
09:50 ET | 1000 | 2.67 |
09:51 ET | 2100 | 2.6912 |
10:06 ET | 1000 | 2.68 |
10:08 ET | 1598 | 2.6928 |
10:09 ET | 113 | 2.6999 |
10:11 ET | 423 | 2.6724 |
10:15 ET | 300 | 2.6747 |
10:18 ET | 996 | 2.66 |
10:20 ET | 212 | 2.65 |
10:38 ET | 500 | 2.66 |
10:44 ET | 900 | 2.6612 |
10:45 ET | 780 | 2.65 |
10:47 ET | 500 | 2.6555 |
10:51 ET | 400 | 2.67 |
10:54 ET | 600 | 2.6812 |
10:56 ET | 100 | 2.67 |
11:18 ET | 1100 | 2.69 |
11:20 ET | 300 | 2.6994 |
11:23 ET | 100 | 2.7 |
11:39 ET | 2450 | 2.69 |
12:19 ET | 400 | 2.69 |
12:28 ET | 891 | 2.6901 |
12:35 ET | 437 | 2.68 |
12:48 ET | 112 | 2.6597 |
01:18 ET | 300 | 2.6962 |
01:22 ET | 590 | 2.658 |
01:24 ET | 100 | 2.6716 |
01:56 ET | 1000 | 2.67 |
02:38 ET | 155 | 2.6504 |
02:54 ET | 100 | 2.65 |
02:59 ET | 500 | 2.66 |
03:06 ET | 205 | 2.66 |
03:12 ET | 500 | 2.65 |
03:28 ET | 208 | 2.6546 |
03:44 ET | 1520 | 2.65 |
03:50 ET | 200 | 2.65 |
04:00 ET | 2984 | 2.68 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vivos Therapeutics Inc | 12.8M | -0.4x | --- |
Scientific Industries Inc | 10.5M | -1.1x | --- |
Lifeward Ltd | 20.6M | -0.8x | --- |
Applied DNA Sciences Inc | 1.9M | 0.0x | --- |
NeuroMetrix Inc | 7.7M | -0.6x | --- |
Innovative Eyewear Inc | 12.7M | -0.7x | --- |
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.8M |
---|---|
Revenue (TTM) | $14.0M |
Shares Outstanding | 4.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 7.67 |
EPS | $-6.98 |
Book Value | $0.22 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -96.23% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.